Brent Furse

Brent Furse has served as a Director and our Chief Executive Officer and President since June 2016. Prior to coming to VERO Biotech, Mr. Furse was a key member of The Medicines Company leadership team where he joined in 2000 pre-IPO and served as a section 16 Officer.

Brent has held various leadership positions including Executive Vice President, Chief Operating Officer, Chief Commercial Officer, Vice President, and General Manager Interventional Medicine, Vice President Surgery and Perioperative Care, and Vice President of Sales and Marketing. He was responsible for the launch and success of their flagship product Angiomax, as well as countless successful partnerships and operational excellence. In addition to his success at The Medicines Company, Brent has held leadership positions with Centers for Disease Control and Prevention, Bristol-Myers Squibb, and Schering Plough Corporation, and serves on the board of Anthera Pharmaceuticals, The Special Olympics, and Salus Tele-health.